China Sky One Medical (the Company) has entered into distribution agreement with Guangdong Mediacy Kind (MDK) engaging MDK to serve as its exclusive sales agent for the company’s AMI diagnostic kit and human urinary albumin Elisa Kit in Southeast Asia.
The distribution agreement has an initial trial period of three months. A more formal contract will be developed to define the annual sales guidelines.
The AMI diagnostic kit is used to diagnose early acute myocardial infarction and the human urinary albumin Elisa kit is used to diagnose early acute kidney disease.
Yan-Qing Liu, chairman and CEO of China Sky One Medical, said: “We look forward to a successful collaboration with MDK on the sale of AMI diagnostic kit and human urinary albumin Elisa kit, both of which have huge market potential.
“As part of growth strategy, we will continue to expand our sales network in Southeast Asia, which is one of the most attractive overseas markets for China Sky One Medical due to its geographical and cultural proximity to China.”